Epidermodysplasia verruciformis.
Burger B, Itin PH.
Curr Probl Dermatol. 2014;45:123-31. doi: 10.1159/000356068. Epub 2014 Mar 17.
Acquired epidermodysplasia verruciformis: clinical presentation and treatment update.
Moore S, Rady P, Tyring S.
Int J Dermatol. 2022 Nov;61(11):1325-1335. doi: 10.1111/ijd.15857. Epub 2021 Aug 17.
Epidermodysplasia Verruciformis: A Study of Clinicopathologic Features, Biomarkers, and Associated Malignancies in Indian Patients.
Mehrotra P, Tirumalae R, Ballal S.
Am J Dermatopathol. 2023 Sep 1;45(9):608-612. doi: 10.1097/DAD.0000000000002491. Epub 2023 Jul 11.
Acquired epidermodysplasia verruciformis syndrome in HIV-infected patients: a systematic review.
Cuestas D, Gómez A, Neri Morales C, Motta A, Rolon M, Suarez S, Polo R.
Arch Dermatol Res. 2024 Jul 13;316(7):471. doi: 10.1007/s00403-024-03016-x.
Severe Epidermodysplasia Verruciformis.
Liu W, Ma DL.
Mayo Clin Proc. 2020 Sep;95(9):2035. doi: 10.1016/j.mayocp.2020.07.010.
Epidermodysplasia verruciformis.
Jablonska S, Orth G.
Clin Dermatol. 1985 Oct-Dec;3(4):83-96. doi: 10.1016/0738-081x(85)90052-5.
Acquired Epidermodysplasia Verruciformis in the Setting of Renal Transplant.
Henning A, Weaver J, Reedy M.
Am J Dermatopathol. 2021 Jan 1;43(1):71-74. doi: 10.1097/DAD.0000000000001696.
Epidermodysplasia verruciformis and susceptibility to HPV.
Patel T, Morrison LK, Rady P, Tyring S.
Dis Markers. 2010;29(3-4):199-206. doi: 10.3233/DMA-2010-0733.
Epidermodysplasia verruciformis and human papilloma virus.
Gewirtzman A, Bartlett B, Tyring S.
Curr Opin Infect Dis. 2008 Apr;21(2):141-6. doi: 10.1097/QCO.0b013e3282f486c9.
[Epidermodysplasia verruciformis].
Aszodi N, Engels L, Hayani K, Flaig MJ, Oppel EM.
Hautarzt. 2020 Jul;71(Suppl 1):47-49. doi: 10.1007/s00105-020-04633-z.
